Efficacy of Topiramate in Preventing Recurrences and Headaches Associated with Idiopathic Intracranial Hypertension: Study Protocol

Update Item Information
Identifier 20230314_nanos_posters_248
Title Efficacy of Topiramate in Preventing Recurrences and Headaches Associated with Idiopathic Intracranial Hypertension: Study Protocol
Creator Fannie Nadeau; Francois Evoy
Affiliation (FN) Sherbrooke University; (FE) University of Sherbrooke
Subject Pseudotumor Cerebri; Neuro-ophthalmology & Systemic Disease (eg. MS, MG, Thyroid); High Intracranial Pressure/Headache
Description Topiramate, FDA approved for migraine prophylaxis, is a promising treatment in IIH because it can reduce ICP, aid weight-loss, and reduce associated headaches. There is little literature about the course and recurrence rate of IIH after discontinuation of standard treatment with acetazolamide. According to two studies, the recurrence rate of the disease is 33-40% in an adult population after acetazolamide cessation.
Date 2023-03-14
Language eng
Format application/pdf
Type Text
Source 2023 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of NANOS Annual Meeting 2023: Poster Session II: Idiopathic Intracranial Hypertension (IIH)
Collection Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/
Publisher North American Neuro-Ophthalmology Society
Holding Institution Spencer S. Eccles Health Sciences Library, University of Utah
Rights Management Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright
ARK ark:/87278/s69dqmyw
Setname ehsl_novel_nam
ID 2335453
Reference URL https://collections.lib.utah.edu/ark:/87278/s69dqmyw
Back to Search Results